Aprea Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.4846 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 6.10M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Details
| Name | Aprea Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 8 |
| Founded | 2006 |
| Ipo Date | 2019-10-03 |
| Ceo | Oren Gilad |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 15.00 |
| Isin | US03836J2015 |
| Cusip | 03836J201 |
| Cik | 1781983 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Oren Gilad Ph.D. | Co-Founder, Chief Executive Officer, President and Director |
| John P. Hamill CPA | Senior Vice President, Chief Financial Officer, Principal Accounting Officer and Secretary |
| Dr. Lars B. Abrahmsen Ph.D. | Senior Vice President and Chief Scientific Officer |
| Brian Wiley | Senior Vice President of Corporate Development and Strategy |
| Dr. Michel Afargan Ph.D. | Head of Pharmacology Development |
| Ze'ev Weiss B.Sc., C.P.A. | Chief Business Advisor |
| Dr. Eugene P. Kennedy F.A.C.S., M.D. | Chief Medical Advisor |
| Andrea Epstein | Controller |
Contact
| Address | 3805 Old Easton Road, Doylestown, Pennsylvania 18902, United States |
| Phone | 215 948 4119 |
| Website | https://aprea.com |